Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.

Monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein of 10 kDa (IP-10) are related members of the CXC chemokine subfamily that bind to a common receptor, CXCR3, and that are produced by different cell types in response to IFN-gamma. We have recently reported that human polymorphonuclear neutrophils (PMN) have the capacity to release IP-10. Herein, we show that PMN also have the ability to produce MIG and to express I-TAC mRNA in response to IFN-gamma in combination with either TNF-alpha or LPS. While IFN-gamma, alone or in association with agonists such as fMLP, IL-8, granulocyte (G)-CSF and granulocyte-macrophage (GM)-CSF, failed to influence MIG, IP-10, and I-TAC gene expression, IFN-alpha, in combination with TNF-alpha, LPS, or IL-1beta, resulted in a considerable induction of IP-10 release by neutrophils. Furthermore, IL-10 and IL-4 significantly suppressed the expression of MIG, IP-10, and I-TAC mRNA and the extracellular production of MIG and IP-10 in neutrophils stimulated with IFN-gamma plus either LPS or TNF-alpha. Finally, supernatants harvested from stimulated PMN induced migration and rapid integrin-dependent adhesion of CXCR3-expressing lymphocytes; these activities were significantly reduced by neutralizing anti-MIG and anti-IP-10 Abs, suggesting that they were mediated by MIG and IP-10 present in the supernatants. Since MIG, IP-10, and I-TAC are potent chemoattractants for NK cells and Th1 lymphocytes, the ability of neutrophils to produce these chemokines might contribute not only to the progression and evolution of the inflammatory response, but also to the regulation of the immune response.

[1]  M. Chilosi,et al.  Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. , 1998, Journal of immunology.

[2]  P. Loetscher,et al.  Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.

[3]  J. Finke,et al.  The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. , 1998, Journal of immunology.

[4]  James G. Boyd,et al.  Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.

[5]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[6]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[7]  C. Mackay,et al.  The chemokine receptor CXCR3 mediates rapid and shear‐resistant adhesion‐induction of effector T lymphocytes by the chemokines IP10 and Mig , 1998, European journal of immunology.

[8]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[9]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[10]  M. Baggiolini,et al.  CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.

[11]  E. Butcher,et al.  Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.

[12]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[13]  T. Hartung,et al.  Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. , 1997, Blood.

[14]  K. Ohuchi,et al.  Induction of neutrophil chemotactic factor production by staurosporine in rat peritoneal neutrophils , 1997, British journal of pharmacology.

[15]  P Signorelli,et al.  Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. , 1997, Journal of the National Cancer Institute.

[16]  J. Farber,et al.  Suppressive effects of recombinant human monokine induced by IFN-gamma (rHuMig) chemokine on the number of committed and primitive hemopoietic progenitors in liquid cultures of CD34+ human bone marrow cells. , 1997, Journal of immunology.

[17]  M. Goldsmith,et al.  Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Teruya-Feldstein,et al.  Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo , 1997 .

[19]  J. Farber Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[20]  A. Luster,et al.  Regulated production of the interferon‐γ‐inducible protein−10 (IP‐10) chemokine by human neutrophils , 1997 .

[21]  C. Haslett,et al.  Granulocyte apoptosis and inflammatory disease. , 1997, British Medical Bulletin.

[22]  M. Cassatella Cytokines Produced by Polymorphonuclear Neutrophils:: Molecular and Biological Aspects , 1996 .

[23]  K. Ebnet,et al.  Regulation of Chemokine Gene Expression in Human Endothelial Cells by Proinflammatory Cytokines and Borrelia burgdorferi , 1996, Annals of the New York Academy of Sciences.

[24]  R. Whyte,et al.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases , 1996, The Journal of experimental medicine.

[25]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[26]  K. Geissler Current status of clinical development of interleukin‐10 , 1996, Current opinion in hematology.

[27]  D. Taub,et al.  Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. , 1996, Blood.

[28]  J. Cavaillon,et al.  IL-10 and IL-4 synergize with TNF-α to induce IL-1ra production by human neutrophils , 1996 .

[29]  R. Rabin,et al.  Human Mig chemokine: biochemical and functional characterization , 1995, The Journal of experimental medicine.

[30]  D. Taub,et al.  Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. , 1995, Journal of immunology.

[31]  A. Angiolillo,et al.  Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells. , 1995, Leukemia & lymphoma.

[32]  M. Burdick,et al.  Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. , 1995, Journal of immunology.

[33]  F. Annunziato,et al.  Polyinosinic acid: polycytidylic acid promotes T helper type 1‐specific immune responses by stimulating macrophage production of interferon‐α and interleukin‐12 , 1995, European journal of immunology.

[34]  R. Strieter,et al.  Interferon‐α and interferon‐γ down‐regulate the production of interleukin‐8 and ENA‐78 in human monocytes , 1995, Journal of leukocyte biology.

[35]  M. Russo,et al.  Regulation of GRO alpha production in human granulocytes. , 1995, Journal of inflammation.

[36]  M. Cassatella The production of cytokines by polymorphonuclear neutrophils. , 1995, Immunology today.

[37]  John A. Smith Neutrophils, host defense, and inflammation: a double‐edged sword , 1994, Journal of leukocyte biology.

[38]  M. Jordana,et al.  Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils , 1994, The Journal of experimental medicine.

[39]  F. Calzetti,et al.  Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation , 1994, The Journal of experimental medicine.

[40]  J. Finke,et al.  Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2. , 1994, The American journal of pathology.

[41]  M. Burdick,et al.  Regulation of neutrophil-derived chemokine expression by IL-10. , 1994, Journal of immunology.

[42]  M. Jordana,et al.  Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. , 1994, American journal of respiratory cell and molecular biology.

[43]  T. Wright,et al.  A unique palindromic element mediates gamma interferon induction of mig gene expression , 1994, Molecular and cellular biology.

[44]  G. Constantin,et al.  Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide , 1993, The Journal of experimental medicine.

[45]  P. Leder,et al.  IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo , 1993, The Journal of experimental medicine.

[46]  J. Krueger,et al.  Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors , 1993, The Journal of experimental medicine.

[47]  F. S. Becker,et al.  Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. , 1993, Journal of immunology.

[48]  M. Colombo,et al.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma , 1993, The Journal of experimental medicine.

[49]  J. Farber HuMig: a new human member of the chemokine family of cytokines. , 1993, Biochemical and biophysical research communications.

[50]  M. Colombo,et al.  Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. , 1992, Cancer research.

[51]  J. Farber,et al.  A collection of mRNA species that are inducible in the RAW 264.7 mouse macrophage cell line by gamma interferon and other agents , 1992, Molecular and cellular biology.

[52]  K. Blaser,et al.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.

[53]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[54]  B. Dewald,et al.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8 , 1991, The Journal of experimental medicine.

[55]  J. Farber,et al.  5' regulatory region of a novel cytokine gene mediates selective activation by interferon gamma , 1991, The Journal of experimental medicine.

[56]  T. Standiford,et al.  Human neutrophils exhibit disparate chemotactic factor gene expression. , 1990, Biochemical and biophysical research communications.

[57]  G. Trinchieri,et al.  Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. , 1990, The Journal of biological chemistry.

[58]  J. Farber,et al.  Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. , 1990, The Journal of biological chemistry.

[59]  Andrew D. Luster,et al.  γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.